title: A novel role for the Receptor for Advanced Glycation End-products in neural progenitor cells derived from adult SubVentricular Zone.
abstract: The Receptor for Advanced Glycation End-products (RAGE) is a member of the immunoglobulin superfamily of cell surface receptors which interacts with a wide range of ligands, such as High-Mobility Group Box-1 (HMGB-1), S100B, advanced glycation end-products (AGEs). Here we provided evidence for the restricted expression of RAGE in the undifferentiated neural stem/progenitor cells of mouse adult SubVentricular Zone (SVZ) neurogenic region and adult SVZ-derived neurospheres. Additionally, RAGE ligands stimulated both proliferation and neuronal differentiation of SVZ-derived neural progenitor cells (NPC) in vitro. NF-kappaB nuclear translocation occurred upon RAGE activation in SVZ-derived neurospheres and its blockade (by SN-50) or its absence (in p50(-/-) derived NPC) resulted in the inhibition of the ligand-mediated effects on neuronal differentiation. These novel findings delineate an interesting scenario where the RAGE-NF-kappaB axis may contribute to regulate adult neural stem/progenitor cell function in physiological and possibly pathological conditions where this axis is upregulated.
authors.affiliation: DiSCAFF, University of Piemonte Orientale A. Avogadro, Novara, Italy.
authors.forename: Vasco
authors.initials: V
authors.lastname: Meneghini
authors.forename: Maria Teresa
authors.initials: MT
authors.lastname: Francese
authors.forename: Lorenzo
authors.initials: L
authors.lastname: Carraro
authors.forename: Mariagrazia
authors.initials: M
authors.lastname: Grilli
mesh_terms: D000818:Animals; D002454:Cell Differentiation / Q000187:drug effects; D002552:Cerebral Ventricles / Q000166:cytology*; D017127:Glycation End Products, Advanced / Q000378:metabolism* / Q000494:pharmacology; D008297:Male; D051379:Mice; D016328:NF-kappa B / Q000378:metabolism; D009419:Nerve Tissue Proteins / Q000378:metabolism*; D058953:Neural Stem Cells / Q000187:drug effects / Q000502:physiology*; D055495:Neurogenesis / Q000187:drug effects; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic / Q000378:metabolism*; D015854:Up-Regulation
chemical_list: D017127:Glycation End Products, Advanced; D016328:NF-kappa B; D009419:Nerve Tissue Proteins; D000067759:Receptor for Advanced Glycation End Products; D011971:Receptors, Immunologic